Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Beam Therapeutics Inc.(BEAM) | 4,540,132 | 4,540,132 | 0 | $88.67M | $77.23M | 25.82% | -$11.44M |
| Vir Biotechnology, Inc.(VIR) | 0 | 12,916,663 | +12,916,663 | $0 | $65.10M | 21.76% | +$65.10M |
| Maze Therapeutics, Inc.(MAZE) | 4,120,053 | 4,120,053 | 0 | $45.36M | $50.59M | 16.91% | +$5.23M |
| Rapport Therapeutics, Inc.(RAPP) | 3,728,738 | 3,728,738 | 0 | $37.55M | $42.43M | 14.19% | +$4.88M |
| Verve Therapeutics Inc. | 2,008,809 | 2,008,809 | 0 | $9.12M | $22.56M | 7.54% | +$13.44M |
| Lyell Immunopharma, Inc.(LYEL) | 0 | 1,820,634 | +1,820,634 | $0 | $16.11M | 5.39% | +$16.11M |
| Erasca, Inc.(ERAS) | 11,055,554 | 11,055,554 | 0 | $15.15M | $14.10M | 4.71% | -$1.05M |
| Gossamer Bio, Inc.(GOSS) | 8,055,916 | 8,055,916 | 0 | $8.78M | $9.91M | 3.31% | +$1.13M |
| Q32 Bio Inc.(QTTB) | 320,482 | 320,482 | 0 | $532.0K | $477.5K | 0.16% | -$54.5K |
| Unity Biotechnology Inc. | 1,004,817 | 1,004,817 | 0 | $1.05M | $385.9K | 0.13% | -$659.1K |
| Cero Therapeutics Holdings Inc. | 0 | 22,389 | +22,389 | $0 | $215.6K | 0.07% | +$215.6K |
| CERo Therapeutics Holdings, Inc.(CERO) | 22,102 | 0 | -22,102 | $16.1K | $0 | — | -$16.1K |